Application

19609523 · USE OF QUINAZOLINE COMPOUND AND THIRD-GENERATION EGFR INHIBITOR IN A COMBINATION MEDICAMENT FOR TREATING NON-SMALL CELL LUNG CANCER

Filed 2026-07-26 · Pending The official file ↗ · Art unit · WEISHANG (HANGZHOU) BIO-PHARMACEUTICAL CO., LTD. · Getech Law LLC

Office actions

first was

RCEs

no appeal

To first action

n/a

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.